Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05451849 |
| Title | A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | TCR2 Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | United States | Details | |
| University of Miami | Miami | Florida | 33146 | United States | Details | |
| National Cancer Institute | Bethesda | Maryland | 20814 | United States | Details | |
| University of Minnesota, Masonic Cancer Center | Minneapolis | Minnesota | 55455 | United States | Details | |
| Montefiore Einstein Cancer Center | Bronx | New York | 10461 | United States | Details | |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| SCRI Oncology Partners | Nashville | Tennessee | 37203 | United States | Details |